Insiders Were the Key Beneficiaries as Mingchen Health Co.,Ltd.'s (SZSE:002919) Market Cap Rises to CN¥3.2b
Insiders Were the Key Beneficiaries as Mingchen Health Co.,Ltd.'s (SZSE:002919) Market Cap Rises to CN¥3.2b
Key Insights
主要见解
- Insiders appear to have a vested interest in Mingchen HealthLtd's growth, as seen by their sizeable ownership
- The top 4 shareholders own 51% of the company
- 22% of Mingchen HealthLtd is held by Institutions
- 内部人似乎对名臣健康有着旺盛的增长兴趣,这可从他们的大规模股权持有看出。
- 前4个股东拥有公司的51%股权。
- 名臣健康有限公司的22%股份由机构持有。
A look at the shareholders of Mingchen Health Co.,Ltd. (SZSE:002919) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 49% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
看一下名臣健康有限公司(深圳证券交易所:002919)的股东情况可以告诉我们哪个群体最强大。我们可以看到,个人内部人持有公司的大部分股权,占有49%。也就是说,如果股票上涨(或者市场出现下行),该群体将获益最多(或者损失最大)。
As a result, insiders scored the highest last week as the company hit CN¥3.2b market cap following a 14% gain in the stock.
由于该公司股价上涨14%,市值达到32亿元人民币,内部人士上周获得最高分。
In the chart below, we zoom in on the different ownership groups of Mingchen HealthLtd.
在下面的图表中,我们放大了名臣健康股份有限公司的不同所有权团体。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240806/0-8e5acd21a48744fb4092344dc7c1679d-0-7e6c8ee1f0e16f1e3fdc84fd5c78044d.png/big)
What Does The Institutional Ownership Tell Us About Mingchen HealthLtd?
机构所有权告诉我们有关名臣健康股份有限公司的什么信息?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
机构投资者通常将自己的回报与常见的指数回报进行比较。因此,他们通常会考虑购买包括在相关基准指数中的较大公司。
We can see that Mingchen HealthLtd does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Mingchen HealthLtd, (below). Of course, keep in mind that there are other factors to consider, too.
我们可以看到,名臣健康股份有限公司确实有机构投资者,并且他们持有公司的相当大一部分股份。这可能表明该公司在投资社区中具有一定的信誉度。但是,最好对依赖机构投资者所提供的所谓验证持谨慎态度。他们也会犯错。如果两家大型机构投资者尝试同时抛售股票,股价大幅下跌并不罕见。因此,检查名臣健康股份有限公司的过去收益轨迹(如下)是值得的。当然,也要记住还有其他因素需要考虑。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240806/0-8e5acd21a48744fb4092344dc7c1679d-1-66188619f93e95c15760f7eaafa15602.png/big)
Hedge funds don't have many shares in Mingchen HealthLtd. Our data shows that Qinfa Chen is the largest shareholder with 35% of shares outstanding. China Asset Management Co. Ltd. is the second largest shareholder owning 5.9% of common stock, and Xinling Wu holds about 5.5% of the company stock.
对于名臣健康有限公司,对冲基金并不持有太多股份。我们的数据显示,陈勤发是最大的股东,持有35%的流通股。中国资产管理股份有限公司是第二大股东,拥有5.9%的普通股,吴新玲持有公司股份的约5.5%。
To make our study more interesting, we found that the top 4 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
为了使我们的研究更有趣,我们发现前四名股东控制了公司一半以上的股份,这意味着该集团对公司的决策具有相当大的影响力。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.
尽管研究公司的机构所有权可以为您的研究增加价值,但还是研究分析师的建议,以深入了解股票预期表现,是一个好习惯。就我们所知,该公司没有分析师覆盖,因此可能没有引起注意。
Insider Ownership Of Mingchen HealthLtd
名臣健康股份有限公司的内部人员所有权
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
虽然内部人员的精确定义可能具有主观性,但几乎所有人都认为董事会成员是内部人员。管理层最终向董事会负责。然而,如果经理是创始人或CEO,那么他们成为执行董事会成员并不罕见。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多数人认为内部所有权是积极的,因为它可以表示董事会与其他股东的利益相一致。但是,在某些场合下,这个团体的权力过于集中。
It seems insiders own a significant proportion of Mingchen Health Co.,Ltd.. It has a market capitalization of just CN¥3.2b, and insiders have CN¥1.6b worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.
看起来,名臣健康股份有限公司的内部人士拥有相当大比例的股份。其市值仅为32亿人民币,内部人士拥有价值16亿人民币的股份。这可能意味着创始人仍拥有大量股份。您可以点击这里查看他们是否一直在买入或卖出。
General Public Ownership
一般大众所有权
With a 24% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Mingchen HealthLtd. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
拥有24%的股权,大部分由个人投资者组成的普通公众对名臣健康股份有限公司有一定的影响力。尽管这样的持股比例相当可观,但如果决策与其他大股东不同步的话,可能不足以改变公司政策。
Private Company Ownership
私有公司的所有权
It seems that Private Companies own 4.5%, of the Mingchen HealthLtd stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.
名臣健康股份有限公司的股份中,私人公司拥有4.5%。私人公司可能是相关方。有时,内部人士通过持有私人公司的股份对一家上市公司产生兴趣,而不是以个人的身份。虽然很难得出任何概括性的结论,但值得注意的是这个领域需要进一步研究。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand Mingchen HealthLtd better, we need to consider many other factors. Take risks for example - Mingchen HealthLtd has 1 warning sign we think you should be aware of.
思考不同的股东群体对一家公司拥有股份的意义总是值得的。但要更好地了解名臣健康股份有限公司,我们需要考虑许多其他因素。例如,承担风险——名臣健康股份有限公司有1个警告信号,我们认为您应该了解。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
当然,您可能会在其他地方找到一项出色的投资。因此,请查看此免费的有趣公司列表。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。